FindTrial
Sign In

Effect of an ayurvedic drug on a viral infection that attack immune system

A RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF YOGARAJ RASYANA IN OJAKSHAYA WITH SPECIAL REFERENCE TO HIV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043626
Enrollment
40
Registered
2022-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

None listed

Sponsors

Patanjali Ayurvedic College
Lead Sponsor
Dr Shivani Karnwal
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient of either sex fulfilling the diagnostic criteria. 2. Diagnosed cases of HIV. 3. CD4 count greater than 350cell/microl 4. Patient not having many complications or many secondary infections. 5. Patients of 16-50 years of age. 6. Good heath at the time of study entry. 7. Patients willing to participate and giving informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient having CD4 count less than 350 cells/micro l 2. Patients below 16 years and above 50 years of age group. 3. Pregnant and lactating women. 4. Patient having multiple opportunistic infections and complications like Diabetes, HTN, Asthma etc.

Design outcomes

Primary

MeasureTime frame
Subjective Parameters 1. Bibheti 2. Daurbalya 3.Duschhaya 4. Durmana 5.Rukshta 6.Bhaktdwesh 7.Jwara 8.Kasa 9.Swaas 10.Atisaar 11.Vaman 12.Shirashool 13.Alpameda 14.Alparaktata 15.Lymphadenopathy Investigations: 1.Full Blood Count 2.ESR 3.RBS 4.SGOT 5.SGPT 6.Blood Urea 7. Serum Creatinine 8. CD4 CountTimepoint: Before intervention of Yogaraj Rasayana orally—

Secondary

MeasureTime frame
Subjective Parameters 1. Bibheti 2. Daurbalya 3.Duschhaya 4. Durmana 5.Rukshta 6.Bhaktdwesh 7.Jwara 8.Kasa 9.Swaas 10.Atisaar 11.Vaman 12.Shirashool 13.Alpameda 14.Alparaktata 15.Lymphadenopathy Investigations: 1.Full Blood Count 2.ESR 3.RBS 4.SGOT 5.SGPT 6.Blood Urea 7. Serum Creatinine 8. CD4 CountTimepoint: After intervention of 3 months with Yogaraj Rasayana orally—

Countries

India

Contacts

Public ContactDr C B Dhanraj

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar

drcbdhanraj@gmail.com7396174582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026